Xynor® (Ornidazole) is a 5-nitroimidazole derivative. It is an anti-microbial agent. It is used in the treatment of susceptible protozoal infections and in the treatment and prophylaxis of anaerobic bacterial infections. The antimicrobial activity of Ornidazole is due to the reduction of the nitro group to a more reactive amine that attacks microbial DNA, brings about loss of helical structure of DNA and subsequent DNA breakage thus inhibiting further synthesis and causing degradation of existing DNA.Xyno® r (Ornidazole) is indicated for: A. Amoebiasis (Intestinal and hepatic) B. Giardiasis C. Trichomoniasis D. Bacterial Vaginosis E. Treatment of susceptible anaerobic infections.

  • Ensures treatment success in Protozoal Infections
  • Effective treatment option for Anaerobic Bacterial Infections
  • Highly effective in Amoebiasis (intestinal and hepatic)

Xynor Prescribing Information

Located in: Anti-infectives